TGM2 and cranioectodermal dysplasia: Because TG2-catalyzed deamidation increases the immunogenicity of gluten-derived peptides by several orders of magnitude4, it is possible that a relatively small molar fraction of absorbed gluten is deamidated in patients with CeD, making the concentrations of these peptide species too low to be detectable.